Melanoma Treatment's hidden cost: study probes fertility damage

NCT ID NCT07138222

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at how immune checkpoint inhibitors (ICIs), a common treatment for melanoma, may affect the reproductive organs and sex hormones in men and women. Researchers will collect blood samples and questionnaires from 80 participants during their regular treatment visits, and men will also provide semen samples. No new treatments are given—this is an observational study to better understand potential side effects on fertility and hormone health.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MELANOMA (SKIN CANCER) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Austin Hospital

    NOT_YET_RECRUITING

    Melbourne, Victoria, 3084, Australia

    Contact

  • Cairns Base Hospital

    NOT_YET_RECRUITING

    Cairns, Queensland, 4870, Australia

    Contact

  • Melanoma Institute Australia

    NOT_YET_RECRUITING

    Sydney, New South Wales, 2065, Australia

    Contact

  • Peter MacCallum Cancer Centre

    RECRUITING

    Melbourne, Victoria, 3000, Australia

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Princess Alexandra Hospital

    NOT_YET_RECRUITING

    Brisbane, Queensland, 4102, Australia

    Contact

  • The Alfred Hospital

    NOT_YET_RECRUITING

    Melbourne, Victoria, 3004, Australia

    Contact

More trials for these conditions

Other studies related to the condition(s) this trial covers.